Medicare Enrolled

Dr. Jaspreet Singh, D.O.

Urology Physician · New Windsor, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
955 LITTLE BRITAIN RD, New Windsor, NY 12553
8454375000
In practice since 2006 (19 years)
NPI: 1598859217 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Jaspreet Singh is an urology physician in New Windsor, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 9,733 Medicare services across 3,479 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $307,499 from 75 pharmaceutical and/or device companies across 916 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in NY $307,499 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,733
Medicare services
Top 9% in NY for urology physician
3,479
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~512 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 4,380 $18 $49
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
1,087 $2 $6
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
651 $101 $337
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
476 $9 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
365 $70 $237
Leuprolide acetate (for depot suspension), 7.5 mg 315 $132 $572
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
282 $8 $11
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
178 $74 $192
PSA test (prostate cancer screening) 134 $18 $46
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
124 $201 $1,040
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
124 $8 $20
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
108 $144 $471
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
101 $9 $61
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
94 $29 $89
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
85 $92 $298
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
82 $10 $26
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
80 $8 $19
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
74 $127 $437
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
72 $18 $46
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
61 $48 $148
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
55 $48 $128
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
53 $51 $281
Bacterial culture, aerobic
A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms.
52 $8 $20
Antibiotic sensitivity test
A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods.
52 $8 $22
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
50 $12 $59
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
49 $112 $317
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
49 $23 $60
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
47 $74 $237
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
41 $21 $206
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
37 $27 $287
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
35 $89 $293
PSA test (prostate cancer screening)
A blood test that measures the level of prostate-specific antigen to screen for prostate cancer.
34 $19 $127
Hormone pellet insertion under the skin
A small hormone pellet is placed just beneath the skin to release medication slowly over time.
33 $79 $255
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
29 $182 $1,089
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
28 $8 $21
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
22 $312 $1,694
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
22 $358 $1,739
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
21 $46 $153
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
20 $173 $588
Sex hormone binding globulin level test
A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream.
17 $21 $54
Laser vaporization of prostate
A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment.
16 $604 $5,004
Stool culture
A laboratory test that grows and identifies bacteria or other microorganisms from a stool sample to detect infections.
16 $9 $24
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
15 $114 $1,782
Other procedure on male genital system
A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories.
14 $239 $4,636
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
14 $25 $65
New patient office visit, complex (60-74 min) 14 $179 $582
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
13 $271 $983
Bladder/urethra growth removal via endoscope, 0.5-2.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters.
12 $212 $644
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
53.7% medium
45.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$307,499
Total received (2018-2024)
Avg $43,928/year across 7 years
Top 1% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
916
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242,802 (79.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$52,716 (17.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,981 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$48,857
2023
$52,004
2022
$41,994
2021
$59,789
2020
$22,494
2019
$44,605
2018
$37,757

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$38,785
Boston Scientific Corporation
$7,937
Astellas Pharma US Inc
$528
Sumitomo Pharma America, Inc.
$252
Antares Pharma, Inc.
$220
Teleflex LLC
$186
Janssen Biotech, Inc.
$159
UROGEN PHARMA, INC.
$79
Endo USA, Inc.
$69
Bayer Healthcare Pharmaceuticals Inc.
$57
Rigicon,Inc.
$55
AIMMUNE THERAPEUTICS, INC.
$44
Phathom Pharmaceuticals, Inc.
$44
Medtronic, Inc.
$40
Myriad Genetic Laboratories, Inc.
$39
PROGENICS PHARMACEUTICALS, INC.
$38
C. R. Bard, Inc. & Subsidiaries
$38
Telix Pharmaceuticals
$34
Merck Sharp & Dohme LLC
$29
Alnylam Pharmaceuticals Inc.
$28
Endo Pharmaceuticals Inc.
$24
Ardelyx, Inc.
$24
ABBVIE INC.
$22
PFIZER INC.
$22
Celltrion USA Inc.
$22
PROCEPT BioRobotics Corporation
$22
Lilly USA, LLC
$21
180 Medical, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
Top 3 companies account for 96.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$134,255
BOSTON SCIENTIFIC CORPORATION
$102,503
COLOPLAST CORP
$38,830
Coloplast Corp
$19,177
NeoTract Inc.
$2,069
Astellas Pharma US Inc
$1,227
Medtronic USA, Inc.
$1,075
Antares Pharma, Inc.
$1,049
PFIZER INC.
$500
Janssen Biotech, Inc.
$438
Teleflex LLC
$430
Medtronic, Inc.
$394
Bayer HealthCare Pharmaceuticals Inc.
$352
Sumitomo Pharma America, Inc.
$320
Endo Pharmaceuticals Inc.
$247
UroGen Pharma, Inc.
$239
AbbVie, Inc.
$230
Ferring Pharmaceuticals Inc.
$217
Cardiovascular Systems Inc.
$192
Amgen Inc.
$182
Axonics, Inc.
$178
AbbVie Inc.
$177
Bard Access Systems, Inc.
$176
Cook Medical LLC
$174
Myriad Genetic Laboratories, Inc.
$153
Alnylam Pharmaceuticals Inc.
$143
Axonics Modulation Technologies, Inc.
$138
Novo Nordisk Inc
$125
Organogenesis Inc.
$119
ABBVIE INC.
$103
UROVANT SCIENCES INC
$95
Rigicon,Inc.
$93
Bayer Healthcare Pharmaceuticals Inc.
$92
Allergan Inc.
$91
Supernus Pharmaceuticals, Inc.
$79
UROGEN PHARMA, INC.
$79
AMAG Pharmaceuticals, Inc.
$78
Allergan, Inc.
$78
KARL STORZ Endoscopy-America
$70
Endo USA, Inc.
$69
AstraZeneca Pharmaceuticals LP
$68
PROCEPT BioRobotics Corporation
$66
180 Medical, Inc.
$66
TherapeuticsMD, Inc.
$66
Olympus Corporation of the Americas
$65
Takeda Pharmaceuticals U.S.A., Inc.
$58
Avadel Specialty Pharmaceuticals, LLC
$56
QOL Medical, LLC
$52
Telix Pharmaceuticals
$51
Tolmar, Inc.
$46
Lilly USA, LLC
$45
AIMMUNE THERAPEUTICS, INC.
$44
Phathom Pharmaceuticals, Inc.
$44
Hollister Incorporated
$42
Acerus Pharmaceuticals Corporation
$40
Progenics Pharmaceuticals, Inc.
$40
PROGENICS PHARMACEUTICALS, INC.
$38
C. R. Bard, Inc. & Subsidiaries
$38
Palette Life Sciences, Inc.
$33
Myovant Sciences Inc.
$30
Merck Sharp & Dohme LLC
$29
Dendreon Pharmaceuticals LLC
$28
Rochester Medical Corporation
$24
Ardelyx, Inc.
$24
Celltrion USA Inc.
$22
EDAP TECHNOMED INC
$19
Olympus America Inc.
$19
DAVOL INC.
$19
Nestle HealthCare Nutrition Inc.
$17
Braintree Laboratories, Inc.
$17
Clarus Therapeutics Inc.
$14
Medtronic Vascular, Inc.
$12
C. R. BARD, INC. & SUBSIDIARIES
$12
Intuitive Surgical, Inc.
$11
Retrophin, Inc.
$10
Top 3 companies account for 89.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 24FR BIPLR COAG ELECTRDE · ADVANCE · ALTIS · AMBICOR · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AMS 800 Artificial Urinary Sphincter · AMS Ambicor · ANNOVERA · AQUABEAM SYSTEM · AVEED · AdVance XP · Androgel · Apligraf · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CONTINENCE CARE · COOK MEDICAL EXTRACTORS · COOK MEDICAL LASERS · Cook Medical Lasers · Cook Medical Stents · Da Vinci Surgical System · ELIGARD · ENDOUROLOGY · EOHILIA · ERLEADA · Enbrel · Erleada · FIRMAGON · GATTEX · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - ERECTILE DYSFUNCTION · GENERAL - KIDNEY STONE DISEASE · GENERAL - THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL MALE SUI · GENERAL PAIN MANAGEMENT · GENTLECATH · GIVLAARI · GREENLIGHT · General - Erectile Dysfunction · General - Kidney Stone Disease · General - Therapies · GreenLight XPS · IBSRELA · ILLUCCIX · IMVEXXY · INTERSTIM · INTRAROSA · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MAGIC3 · MYCAMINE · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PKG/6 · PROGEL · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · RIGI10 MALLEABLE PENILE PROSTHESIS · RINVOQ · RYBELSUS · Rigi10 Malleable Penile Prosthesis · SPACEOAR VUE · SPEEDICATH · STERILE · SUCRAID · SUTAB · SUTENT · SpaceOAR VUE System - 10mL · SpeediCath · Sucraid · TACTRA · TALTZ · THERAPIES · TOVIAZ · TREMFYA · Titan · UROLIFT · UroLift · UroLift System · VEGZELMA · VOQUEZNA · VaPro Pocket · VenaSeal · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZENPEP · ZEPBOUND · ZYTIGA · iTIND System · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in NY.

Looking for an urology physician in New Windsor?
Compare urology physicians in the New Windsor area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
43
Per 100K population
10.6
County median income
$96,497
Nearest hospital
MONTEFIORE ST LUKE'S CORNWALL
5.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a mixed practice specialist, with above-average Medicare volume (top 9% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Singh performed 4,380 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $307,499 from 75 companies across 916 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other urology physicians in New Windsor?
Dr. Singh's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →